Radioactive contamination in feral dogs in the Chernobyl exclusion zone: Population body-burden survey and implications for human radiation exposure.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 20 05 2022
accepted: 03 03 2023
medline: 23 10 2023
pubmed: 20 7 2023
entrez: 20 7 2023
Statut: epublish

Résumé

This report describes a two-year effort to survey the internal 137Cs and external β-emitter contamination present in the feral dog population near the Chernobyl nuclear power plant (ChNPP) site, and to understand the potential for human radiation exposure from this contamination. This work was performed as an integral part of the radiation safety and control procedures of an animal welfare oriented trap-neuter-release (TNR) program. The measurement program focused on external contamination surveys using handheld β-sensitive probes, and internal contamination studies using a simple whole-body counter. Internal 137Cs burden was measured non-invasively during post-surgical observation and recovery. External β contamination surveys performed during intake showed that 21/288 animals had significant, removable external contamination, though not enough to pose a large hazard for incidental contact. Measurements with the whole-body counter indicated internal 137Cs body burdens ranging from undetectable (minimum detection level ∼100 Bq/kg in 2017, ∼30 Bq/kg in 2018) to approximately 30,000 Bq/kg. A total of 33 animals had 137Cs body-burdens above 1 kBq/kg, though none posed an external exposure hazard. The large variation in the 137Cs concentration in these animals is not well-understood, could be due to prey selection, access to human food scraps, or extended residence in highly contaminated areas. The small minority of animals with external contamination may pose a contamination risk allowing exposures in excess of regulatory standards.

Identifiants

pubmed: 37471331
doi: 10.1371/journal.pone.0283206
pii: PONE-D-22-14715
pmc: PMC10358910
doi:

Substances chimiques

Cesium-137 4T2E65IAR7
Cesium Radioisotopes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0283206

Informations de copyright

Copyright: © 2023 Hecla et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

RT was employed by the company Tubbs Nuclear Consulting (and likewise volunteered his time). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

J Radiat Res. 2018 Nov 1;59(6):765-766
pubmed: 30247651
Radiat Environ Biophys. 2005 Dec;44(3):161-8
pubmed: 16237535
Radiat Environ Biophys. 2006 Sep;45(3):167-77
pubmed: 16862442
Radiat Environ Biophys. 2020 Aug;59(3):415-421
pubmed: 32468176
Sci Total Environ. 2002 May 27;291(1-3):1-32
pubmed: 12150429
Curr Biol. 2015 Oct 5;25(19):R824-6
pubmed: 26439334
Health Phys. 2011 Oct;101(4):416-30
pubmed: 21878767
Health Phys. 2007 Nov;93(5):427-40
pubmed: 18049219
Cancer Epidemiol. 2021 Oct;74:102015
pubmed: 34455236
Nat Rev Cancer. 2002 Jul;2(7):543-9
pubmed: 12094241
Health Phys. 2011 Oct;101(4):431-41
pubmed: 21878768

Auteurs

Jake Hecla (J)

Department of Nuclear Engineering, University of California Berkeley, Berkeley, California, United States of America.
Clean Futures Fund, Godfrey, Illinois, United States of America.

Erik Kambarian (E)

Clean Futures Fund, Godfrey, Illinois, United States of America.

Robert Tubbs (R)

Tubbs Nuclear Consulting, Auburn, Washington, United States of America.

Carla McKinley (C)

Department of Nuclear Engineering, University of California Berkeley, Berkeley, California, United States of America.

Aaron J Berliner (AJ)

Department of Nuclear Engineering, University of California Berkeley, Berkeley, California, United States of America.
Department of Bioengineering, University of California Berkeley, Berkeley, California, United States of America.

Kayla Russell (K)

School of Veterinary Medicine, University College Dublin, Dublin, Ireland.

Gabrielle Spatola (G)

Department of Biological Sciences, University of South Carolina, Columbia, South California, United States of America.

Jordan Chertok (J)

College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, United States of America.

Weston Braun (W)

Department of Electrical Engineering, Stanford University, Palo Alto, California, United States of America.

Natalia Hank (N)

College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, United States of America.

Courtney Marquette (C)

School of Veterinary Medicine, University College Dublin, Dublin, Ireland.

Jennifer Betz (J)

Clean Futures Fund, Godfrey, Illinois, United States of America.

Terry Paik (T)

Clean Futures Fund, Godfrey, Illinois, United States of America.

Marie Chenery (M)

Clean Futures Fund, Godfrey, Illinois, United States of America.

Alex Cagan (A)

Wellcome Sanger Institute, Hinxton, United Kingdom.

Carl Willis (C)

Department of Nuclear Engineering, University of New Mexico, Albuquerque, New Mexico, United States of America.

Tim Mousseau (T)

Department of Biological Sciences, University of South Carolina, Columbia, South California, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH